Pedro M. Rojas
Nessuna posizione attualmente
Storia della carriera di Pedro M. Rojas
Precedenti posizioni note di Pedro M. Rojas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Q-RNA, Inc.
 Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Oligomerix, Inc.
 Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Fondatore | 25/01/2010 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Retail Trade | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Oligomerix, Inc.
Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Retail Trade |
Q-RNA, Inc.
Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Pedro M. Rojas
- Esperienza
